Grace Therapeutics, Inc. (GRCE)

EPS

-1.26

TTM · Period ending: · USD

GRCE logo

GRCE EPS

Latest reported-1.26
GRCE TTM EPS (-43.86 → -1.26)
High-resolution chart · PNG

GRCE eps history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Grace Therapeutics, Inc. EPS — Trailing twelve months (TTM) (USD)
Period endingEPS (USD)
-1.2557
-0.5557
-0.4175
-0.7475
-0.9653
-1.0853
-1.57
-1.33
-1.62
-2.01
-6.88
-7.3
-7.37
-7.44
-2.87
-2.82
-1.93
-2.24
-5.43
-7.3
-13.03
-16.47
6.3
2.11
-4.61
-5.47
-33.79
-29.37
-40.19
-43.3
-51.51
-64.45
-53.25
-51.71
-42.03
-34.77
-33.77
-32.98
-32.37
-28.62
-21.28
-23.66
-3
-14.21
-5.91
-6.95
-41
-44.73
-62.04
-64.02
-53.95
-46.44
-44.03
-44.4
-48.41
-49.87
-47.64
-44.09
-35.29
-28.82
-26.12
-23.26
-24.38
-40.08
-49.31
-43.8629
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.